Assignee
CONARIS RES INSTITUTE AG
DE·4 granted patents·6 pending applications·2 citations·filing 2013–2023
Top patents by PatentIndex Score
10 records- 0174US10758552B2Pharmaceutical composition containing combinations of nicotinamide and 5-aminosalicylic acid for beneficially influencing the intestinal microbiota and/or treating gastrointestinal inflammationCONARIS RES INSTITUTE AG·Filed 2014·Granted Sep 1, 2020·1 cites·14 claims
- 0272US10426765B2Pharmaceutical composition containing nicotinic acid and/or nicotinamide and/or tryptophan for positively influencing the intestinal microbiotaCONARIS RES INSTITUTE AG·Filed 2013·Granted Oct 1, 2019·1 cites·24 claims
- 0371US2025268885A1Oral composition comprising nicotinamideCONARIS RES INSTITUTE AG·Filed 2023·Application pending·0 cites
- 0460US2025213549A1Composition comprising nicotinamide, nicotinamide precursors, nicotinamide metabolites or combinations thereof for preventing or reducing one or more post-acute symptoms of infectious diseasesCONARIS RES INSTITUTE AG·Filed 2023·Application pending·0 cites
- 0558US2020009124A1Pharmaceutical composition containing nicotinic acid and/or nicotinamide and/or tryptophan for positively influencing the intestinal microbiotaCONARIS RES INSTITUTE AG·Filed 2019·Application pending·0 cites
- 0654US10888555B2Pharmaceutical composition containing nicotinic acid and/or nicotinamide for beneficially influencing blood lipid levels by modifying the intestinal microbiotaCONARIS RES INSTITUTE AG·Filed 2014·Granted Jan 12, 2021·0 cites·30 claims
- 0754US2023414599A1Nicotinamide, nicotinamide precursors and nicotinamide metabolites and compositions thereof for reducing the time to resolution of symptoms in patients with covid-19 and other viral infectionsCONARIS RES INSTITUTE AG·Filed 2021·Application pending·0 cites
- 0842US2021275513A1Shellac microcapsule formulations and compositions for topical intestinal delivery of vitamin b3CONARIS RES INSTITUTE AG·Filed 2017·Application pending·0 cites
- 0942US2019105278A1Shellac microcapsule formulations and compositionsCONARIS RES INSTITUTE AG·Filed 2017·Application pending·0 cites
- 1038US11622938B2Oral pharmaceutical compositions of nicotinamideCONARIS RES INSTITUTE AG·Filed 2017·Granted Apr 11, 2023·0 cites·16 claims
Join the waitlist — get patent alerts
Get an alert when CONARIS RES INSTITUTE AG files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →